Aims and Scope
PR&P is jointly published by the American Society for Pharmacology and Experimental Therapeutics (ASPET), the British Pharmacological Society (BPS), and Wiley. PR&P is a bi-monthly open access journal that publishes a range of article types, including: target validation (preclinical papers that show a hypothesis is incorrect or papers on drugs that have failed in early clinical development); drug discovery reviews (strategy, hypotheses, and data resulting in a successful therapeutic drug); frontiers in translational medicine (drug and target validation for an unmet therapeutic need); pharmacological hypotheses (reviews that are oriented to inform a novel hypothesis); and replication studies (work that refutes key findings [failed replication] and work that validates key findings). PR&P publishes papers submitted directly to the journal and those referred from the journals of ASPET and the BPS.
Open Access and Copyright
All articles published by Pharmacology Research & Perspectives are fully open access: immediately freely available to read, download and share. All Pharmacology Research & Perspectives articles are published under the terms of a Creative Commons Attribution License. Copyright on any research article in a journal published by Pharmacology Research & Perspectives is retained by the author(s). Authors grant Wiley a license to publish the article and identify itself as the original publisher. Further information about copyright and the choice of open access licenses can be found here.
Abstracting and Indexing Information
- Academic Search (EBSCO Publishing)
- Academic Search Alumni Edition (EBSCO Publishing)
- Academic Search Complete (EBSCO Publishing)
- Academic Search Elite (EBSCO Publishing)
- Academic Search Premier (EBSCO Publishing)
- Biomedical Reference Collection (EBSCO Publishing)
- CAS: Chemical Abstracts Service (ACS)
- Embase (Elsevier)
- Health Research Premium Collection (ProQuest)
- ProQuest Central (ProQuest)
- ProQuest Health & Medical Complete (ProQuest)
In Memoriam: Darrell R. Abernethy, M.D. Ph.D.
It is with deep sadness that the Editorial Team at PR&P must convey the news that Darrell Abernethy, Editor in Chief of the Journal, has recently passed away. Darrell has been instrumental in raising the profile and quality of PR&P in both his roles on the Journal, first as Deputy Editor and then Editor. He has been a true inspiration to so many of our authors and editors who work in the field of pharmacology, very much a team player, providing considered and thoughtful responses. His wise counsel will be missed.
Rest in peace
PR&P Editorial Team
Darrell's obituary can be viewed on the ASPET website